Core Viewpoint - 华测检测's stock performance shows a slight decline, with significant trading activity and high financing levels, indicating investor interest and potential volatility in the market [1][2]. Financing and Trading Activity - On September 17, 华测检测 experienced a 0.38% drop in stock price, with a trading volume of 375 million yuan. The financing buy-in amounted to 58.62 million yuan, while financing repayment was 35.37 million yuan, resulting in a net financing buy of 23.25 million yuan. The total financing and margin balance reached 676 million yuan [1]. - The current financing balance stands at 661 million yuan, representing 3.01% of the market capitalization, which is above the 90th percentile of the past year, indicating a high level of financing activity [1]. - In terms of margin trading, 4,700 shares were repaid, and 34,900 shares were sold short, with a total short sale value of approximately 455,800 yuan. The remaining short position is 1.20 million shares, with a margin balance of 15.62 million yuan, also above the 90th percentile of the past year [1]. Company Performance - As of June 30, 华测检测 reported a total of 81,100 shareholders, an increase of 4.53% from the previous period. The average number of circulating shares per shareholder decreased by 4.34% to 17,647 shares [2]. - For the first half of 2025, 华测检测 achieved a revenue of 2.96 billion yuan, reflecting a year-on-year growth of 6.05%. The net profit attributable to shareholders was 467 million yuan, marking a 7.03% increase compared to the previous year [2]. Dividend and Shareholder Information - Since its A-share listing, 华测检测 has distributed a total of 1.08 billion yuan in dividends, with 436 million yuan distributed over the past three years [3]. - As of June 30, 2025, the largest circulating shareholder is Hong Kong Central Clearing Limited, holding 269 million shares, an increase of 7.87 million shares from the previous period. Other notable shareholders include 易方达创业板ETF and 南方中证500ETF, with varying changes in their holdings [3].
华测检测9月17日获融资买入5861.92万元,融资余额6.61亿元